Design and characterization of 3D-printed hollow microneedle arrays for transdermal insulin delivery
Source abstract
Abstract
The delivery of insulin to diabetic patients remains a challenge due to the limitations of current insulin delivery paradigms, including painful cannula insertion, potential infections, interference with activity, embarrassment, and sometimes cost. To address this problem, we designed and fabricated nine prototypes of stereolithographic 3D-printed microneedle arrays (MNAs) appropriate for the minimally invasive delivery of insulin. We characterized their transdermal penetration performance by delivering fluid at a constant rate to porcine skin through these MNAs. Moreover, we characterized the force required for these MNAs to puncture porcine skin using a mechanical testing apparatus. We developed an improved method of mechanical testing for the MNAs against porcine skin by incorporating an imitation soft tissue layer under the skin and compared the MNA results with those using a single microneedle and a hypodermic needle. In addition, we investigated the mechanical flexural strength of the MNAs by performing a flexural failure load test on them. We confirmed that the prototype MNAs are mechanically robust and do not fracture during skin penetration, setting the stage for future trials in vitro and in vivo. The final, optimized designs are freely available in stereolithography (STL) file format.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Bee Products Chemical Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering and Mechanics, Virginia Tech 1 , Blacksburg, Virginia 24061, USA
Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences 2 , Blacksburg, Virginia 24061, USA
Funding
Virginia Polytechnic Institute and State University
References (86)
Show source-provided references
1. Insulin delivery methods: Past, present and future10.4103/2230-973x.176456 ↗
2. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery10.1039/d0bm00743a ↗
3. Crosslinked zwitterionic microcapsules to overcome gastrointestinal barriers for oral insulin delivery10.1039/d2bm01606k ↗
4. Oral delivery of macromolecules using intestinal patches: Applications for insulin delivery10.1016/j.jconrel.2004.04.013 ↗
5. Preparation and improvement of release behavior of chitosan microspheres containing insulin10.1016/j.ijpharm.2005.12.033 ↗
6. Oral insulin delivery platforms: Strategies to address the biological barriers10.1002/anie.202008879 ↗
7. Versatile oral insulin delivery nanosystems: From materials to nanostructures10.3390/ijms23063362 ↗
8. Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery10.1016/j.addr.2012.10.007 ↗
9. Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations10.1016/j.ddtec.2011.12.001 ↗
10. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers10.1021/acsami.6b08183 ↗
11. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery10.1007/s11095-011-0419-4 ↗
12. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: A potential approach for delivery of drugs having high first-pass metabolism10.3109/10717544.2013.779331 ↗
13. Advantageous nasal drug delivery system: A review10.13040/IJPSR.0975-8232.2(6).1322-36 ↗
14. Diabetes technology update: Use of insulin pumps and continuous glucose monitoring in the hospital10.2337/dci18-0002 ↗
15. Trends in insulin types and devices used by adults with type 2 diabetes in the United States, 2016 to 202010.1001/jamanetworkopen.2021.28782 ↗
16. Reducing pain during vaccine injections: Clinical practice guideline10.1503/cmaj.150391 ↗
17. Procedural and physical interventions for vaccine injections: Systematic review of randomized controlled trials and quasi-randomized controlled trials10.1097/ajp.0000000000000264 ↗
18. Pharmacological and combined interventions to reduce vaccine injection pain in children and adults: Systematic review and meta-analysis10.1097/ajp.0000000000000281 ↗
19. Challenges and recent advances in the subcutaneous delivery of insulin10.1080/17425247.2016.1232247 ↗
20. Microneedle array patches integrated with nanoparticles for therapy and diagnosis10.1002/sstr.202000097 ↗
21. Advances in transdermal insulin delivery10.1016/j.addr.2018.12.006 ↗
22. Recent progress in polymeric non-invasive insulin delivery10.1016/j.ijbiomac.2022.01.134 ↗
23. (Trans) dermal insulin delivery based on polymeric systems10.1080/00914037.2018.1534113 ↗
24. Smart microneedle patches for rapid, and painless transdermal insulin delivery10.1039/d0tb01822h ↗
25. Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery10.1038/s41378-020-00224-z ↗
26. Transdermal delivery of insulin using microneedle rollers in vivo10.1016/j.ijpharm.2010.03.041 ↗
27. HELPinKids&Adults knowledge synthesis of the management of vaccination pain and high levels of needle fear: Limitations of the evidence and recommendations for future research10.1097/ajp.0000000000000266 ↗
28. Persistent shoulder pain after vaccine administration is associated with common incidental pathology: A systematic review10.1097/corr.0000000000002191 ↗
29. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: A systematic review10.1111/dme.12128 ↗
30. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study10.1111/j.1464-5491.2012.03605.x ↗
31. Adherence to insulin therapy10.2337/diaspect.29.3.166 ↗
32. Cost-related medication non-adherence among U.S. adults with diabetes10.1016/j.diabres.2018.06.016 ↗
33. Capabilities of next-generation patch pump: Improved precision, instant occlusion detection, and dual-hormone therapy10.1177/1932296818776028 ↗
34. An RF-driven lightweight implantable insulin pump
35. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development10.1016/j.mser.2016.03.001 ↗
36. The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis10.1016/j.addr.2021.06.002 ↗
37. Microneedle array systems for long-acting drug delivery10.1016/j.ejpb.2020.12.006 ↗
38. A PZT insulin pump integrated with a silicon microneedle array for transdermal drug delivery10.1007/s10404-006-0083-x ↗
39. Advances of microneedles in biomedical applications10.3390/molecules26195912 ↗
40. 3D-printed microneedle arrays for drug delivery10.1016/j.jconrel.2022.08.022 ↗
41. A hollow stainless steel microneedle array to deliver insulin to a diabetic rat10.1088/0960-1317/26/6/065013 ↗
42. Transdermal delivery of siRNA through microneedle array10.1038/srep21422 ↗
43. In vivo experimental study of noninvasive insulin microinjection through hollow Si microneedle array10.3390/mi9010040 ↗
44. A 3D-printed microfluidic-enabled hollow microneedle architecture for transdermal drug delivery10.1063/1.5127778 ↗
45. Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery10.1016/j.actbio.2020.12.023 ↗
46. Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays10.1007/s13346-015-0238-y ↗
47. Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery10.1007/s12274-020-3273-z ↗
48. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery10.1016/j.jconrel.2020.03.026 ↗
49. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: Development and in vitro evaluation10.1007/s10544-015-9944-y ↗
50. Hollow microneedle arrays produced by low-cost, high-fidelity replication of hypodermic needle tips for high-dose transdermal drug delivery10.1002/adem.202170020 ↗
51. A novel 3D printed hollow microneedle microelectromechanical system for controlled, personalized transdermal drug delivery10.1016/j.addma.2020.101815 ↗
52. Fast customization of hollow microneedle patches for insulin delivery10.18063/ijb.v8i2.553 ↗
53. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol10.1088/0960-1317/16/3/001 ↗
54. Rapid fabrication method of a microneedle mold with controllable needle height and width10.1007/s10544-016-0113-8 ↗
55. Microneedles for drug and vaccine delivery10.1016/j.addr.2012.04.005 ↗
56. 3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery10.1016/j.msec.2019.04.063 ↗
57. Transdermal delivery of insulin across human skin in vitro with 3D printed hollow microneedles10.1016/j.jddst.2021.102891 ↗
58. S. Zhang , “InsulPatch: A slim, powerless microfluidic patch-pump for insulin delivery,” in ETDs: Virginia Tech Electronic Thesis and Dissertations (Virginia Tech, 2021).
59. A slim, powerless microfluidic patch-pump for transdermal drug delivery
60. Frequency-specific, valveless flow control in insect-mimetic microfluidic devices10.1088/1748-3190/abe4bc ↗
61. Staples-lab/MNA-STL-files: MNA-STL-files1.2
62. Correlation between porcine and human skin models by optical methods
63. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models10.1016/j.addr.2007.07.004 ↗
64. Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy10.1016/j.jphotobiol.2009.07.001 ↗
65. Swine as models in biomedical research and toxicology testing10.1177/0300985811402846 ↗
66. Porcine ear skin: An in vitro model for human skin10.1111/j.1600-0846.2006.00179.x ↗
67. Skin models for the testing of transdermal drugs10.2147/cpaa.s64788 ↗
68. Pig ear skin as an in-vitro model for human skin permeability10.1111/j.2042-7158.1992.tb05485.x ↗
69. Characterization of porcine skin as a model for human skin studies using infrared spectroscopic imaging10.1039/c1an15111h ↗
70. The immunology of the porcine skin and its value as a model for human skin10.1016/j.molimm.2014.10.023 ↗
71. Microneedles for transdermal drug delivery: A systematic review10.1080/03639045.2018.1539497 ↗
72. Microneedles: A versatile strategy for transdermal delivery of biological molecules10.1016/j.ijbiomac.2017.12.027 ↗
73. Sex- and site-dependent variations in the thickness and mechanical properties of human skin in vivo10.1046/j.1467-2494.2000.00037.x ↗
74. Skin thickness of Korean adults10.1007/s00276-002-0034-5 ↗
75. Forearm skin aging: Characterization by instrumental measurements10.1111/ics.12407 ↗
76. The influence of gender and age on the thickness and echo-density of skin10.1111/srt.12294 ↗
77. Formlabs, Materials library: Functional materials that look the part, www document, https://formlabs-media.formlabs.com/filer_public/ac/89/ac8963db-f54a-4cac-8fe9-fb740a7b06f1/formlabs-materials-library.pdf.
78. Use of silicone materials to simulate tissue biomechanics as related to deep tissue injury10.1097/01.asw.0000460127.47415.6e ↗
79. The relationship between the Young’s modulus of the stratum corneum and age: A pilot study10.1111/srt.12054 ↗
80. Sharpening of hollow silicon microneedles to reduce skin penetration force10.1088/0960-1317/20/4/045011 ↗
81. Insertion of microneedles into skin: Measurement and prediction of insertion force and needle fracture force10.1016/j.jbiomech.2003.12.010 ↗
82. 3D printed hollow microneedles array using stereolithography for efficient transdermal delivery of rifampicin10.1016/j.ijpharm.2021.120815 ↗
83. Hollow metal microneedles for insulin delivery to diabetic rats10.1109/tbme.2005.845240 ↗
84. Design, fabrication, and characterisation of a silicon microneedle array for transdermal therapeutic delivery using a single step wet etch process10.1016/j.ejpb.2021.06.005 ↗
85. Microneedles in drug delivery: Progress and challenges10.3390/mi12111321 ↗
86. MNA article data repository 3